Navigation Links
Researchers discover which organs in Antarctic fish produce antifreeze

Thirty-five years ago Arthur DeVries of the University of Illinois at Urbana-Champaign first documented antifreeze glycoproteins (AFGPs) in Antarctic notothenioid fishes. This month three colleagues report they've solved the ensuing, long-running mystery of where these AFGPs, which allow the fish to survive in icy waters, are produced.

"Ever since the discovery of these antifreeze proteins, it was assumed they had to be produced in the liver, since the vertebrate liver is well known as a source of secreted plasma protein, so there was no reason to think otherwise," said Chi-Hing "Christina" C. Cheng, a professor of animal biology. "It turns out that the liver has no role in the freezing avoidance in these fishes at all."

Instead, antifreeze glycoproteins (AFGP) originate primarily from the exocrine pancreas and the stomach, say Cheng, Paul A. Cziko and Clive W. Evans in a paper appearing online this week ahead of regular publication in the Proceedings of the National Academy of Sciences.

Cziko is a research specialist at Illinois. Evans is a professor of molecular genetics and development at the University of Auckland in New Zealand.

The liver-synthesis mindset dominated earlier studies even though results appeared to be at odds, Cheng said. The first radioactive-tracer characterization of liver AFGP biosynthesis, in fact, suggested another source of production was possible. Later on, Northern-blot studies had shown very low expression levels of antifreeze messenger RNA in the liver, but this was inconsistent with high levels of production of the protein, the researchers noted.

Cheng and colleagues used Northern blots of total RNA from various tissues to hybridize with an AFGP gene probe. A clear picture of strong AFGP mRNA expression came into focus in the pancreatic tissues in all notothenioids tested. The use of cDNA cloning and sequencing showed that the mRNA all encode secreted AFGPs.

An RNA analysis from tissues of a single notothenioid unveiled the anterior portion of the stomach, next to the esophagus-stomach junction, as being the only other site with strong AFGP mRNA expression. Using antibodies, the researchers found the absence of liver synthesis and strong pancreas expression in newly hatched fish larvae and young juveniles.

The exocrine pancreas is the larger of the two parts that make up the pancreas. It consists of tubuloacinar glands that primarily manufacture and secrete digestive enzymes that break down food in the intestine so it can be absorbed.

In this case, AFGPs are secreted into the intestinal lumen where they protect the intestinal fluid from being frozen by ice crystals that come in with seawater and food. Internal fluids in notothenioids are about one-half as salty as seawater.

While seawater reaches its freezing point at ?.91 degrees Celsius, fish fluids freeze at about ? degree Celsius. These species dwell in water that rarely rises above the freezing point and is regularly filled with ice crystals.

From the intestine, the AFGPs are, apparently, absorbed into the blood. This hypothesis is based on the near-identical composition and abundance of AFGPs found in the fish serum.

"In this comprehensive study, we confirm that the exocrine pancreas is the major AFGP synthesis site in Antarctic notothenioid fishes from hatching through adulthood, while the liver is AFGP-expression null in all life stages," the researchers conclude. "Because the notothenioids are confined to chronically icy Antarctic waters, and face high risks of ice inoculation from frequent seawater drinking, the evolution of AFGPs in these fishes was probably driven first and foremost by the need to prevent the hyposmotic intestinal fluid from freezing."

The researchers also studied a variety of fishes from Arctic waters that have liver expression of AFGPs, and found that all of them also express antifreeze in the pancreas.

The fin dings, they wrote, bring a new perspective to teleost freeze-avoidance physiology and "reveals that the long-held paradigm of hepatic-based AF synthesis and secretion is no longer universally applicable." Instead, pancreatic antifreeze expression is universal.


'"/>

Source:University of Illinois at Urbana-Champaign


Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
Breaking Biology Technology: